Personality disorders and substance use disorders: a narrative review
Keywords:
Comorbidity, Personality disorders, Substance use disordersAbstract
Background: Personality factors have always been considered to play an important role in the etiology of
substance-related disorders. Psychopathologic factors underlying an individual's personality structure have a
major role in his or her tendency to use substances. This comorbidity can have an adverse effect on seeking and
complying with treatment.
Objective: This review provides the comorbidity of personality disorders and substance use disorders (SUD).
Methods: In this report which was conducted in 2016, authors gathered data from different journals issued in
print or electronic versions. These journals were indexed in Web of Science (Thomson Reuters), PubMed,
Scopus, Google Scholar, ProQuest, Science Direct, Scientific Information Database (SID) and Magiran. A
comprehensive search was done using keywords “Comorbidity”, “Personality disorders” and “Substance use
disorders”. The research investigated in this review was conducted from January 1995 to 2016.
Results: Comorbidity of borderline personality disorder, antisocial personality and diagnostic and therapeutic
considerations are the most well-known problems in personality disorder. In dealing with these patients special
attention should be paid to their safety, suicidal and homicidal thoughts
Conclusion: It should be noted that an early diagnosis of comorbid personality disorder would lead to an adjusted
expectancy from treatment, and adoption of long-term treatments for these patients
References
Cloninger CR, Svrakic DM. Personality disorders. The medical basis of psychiatry. Springer. 2016: 537- 50. doi: 10.1007/978-1-4939-2528-5_28.
Korsgaard HO, Torgersen S, Wentzel-Larsen T, Ulberg R. Substance abuse and personality disorder
comorbidity in adolescent outpatients: are girls more severely ill than boys? Child Adolesc Psychiatry Ment
Health. 2016; 10(1): 1. doi: 10.1186/s13034-016-0096-5. PMID: 27069507, PMCID: PMC4827187.
Carpenter RW, Wood PK, Trull TJ. Comorbidity of borderline personality disorder and lifetime substance
use disorders in a nationally representative sample. J Pers Disord. 2016; 30(3): 336-50. doi:
1521/pedi_2015_29_197. PMID: 25893556.
Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol,
controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin
Psychopharm. 1994; 2(3): 244. doi: 10.1037//1064-1297.2.3.244.
Moeller FG, Dougherty DM, Barratt ES, Oderinde V, Mathias CW, Harper RA, et al. Increased impulsivity
in cocaine dependent subjects independent of antisocial personality disorder and aggression. Drug Alcohol
Depend. 2002; 68(1): 105-11. doi: 10.1016/S0376-8716(02)00106-0. PMID: 12167556.
Miller JD, Lyman DR, Widiger TA, Leukefeld C. Personality disorders as extreme variants of common
personality dimensions: can the five factor model adequately represent psychopathy? J Pers. 2001; 69(2):
-76. PMID: 11339798.
Casillas A, Clark LA. Dependency, impulsivity and self-harm: traits hypothesized to underlie the
association between cluster B personality and substance use disorders. J Pers Disord. 2002; 16(5): 424-36.
PMID: 12489309.
Alemikhah M, Farid Hosseini f, Rajaei AR, Rasouli Azad M, Kordi H. Comparison of brain behavioral
systems between methamphetamine dependent and normal people; based on Gray’s revised reinforcement
sensitivity theory. Journal of Fundamentals of Mental Health. 2013; 15(57): 17-26.
Ball SA, Tennen H, Poling JC, Kranzler HR, Rounsaville BJ. Personality, temperament, and character
dimensions and the DSM-IV personality disorders in substance abusers. J Abnorm Psychol. 1997; 106(4):
doi: 10.1037/0021-843X.106.4.545. PMID: 9358685.
Rounsaville BJ, Kranzler HR, Ball S, Tennen H, Poling J, Triffleman E. Personality disorders in substance
abusers: relation to substance use. J Nerv Ment Dis. 1998; 186(2): 87-95. doi: 10.1097/00005053- 199802000-00004. PMID: 9484308.
Tull MT, Gratz KL. The impact of borderline personality disorder on residential substance abuse treatment
dropout among men. Drug Alcohol Depend. 2012; 121(1): 97-102. doi: 10.1016/j.drugalcdep.2011.08.014.
PMID: 21907503, PMCID: PMC3237890.
Liotti G. Borderline Personality Disorders. Eur Psychiatry. 2015; 30: 4. doi: 10.1016/S0924- 9338(15)30002-X.
Ritschel LA, Kilpela LS. Borderline Personality Disorder. The Encyclopedia of Clinical Psychology. 2015.
doi: 10.1002/9781118625392.wbecp478.
Flory JD. Defining the construct of reactive aggression in borderline personality disorder: Commentary on
“Aggression in borderline personality disorder—A multidimensional model”. Personal Disord. 2015; 6(3):
-5. doi: 10.1037/per0000134. PMID: 26191824.
Malayeri A, Kaviani H, Asadi S, Farid Hoseini F. Evaluation of personality dimensions using the Cloninger
Temperament and Character Inventory in subjects with borderline personality disorders. Tehran Univ Med
J. 2008; 66(9): 633-8.
Maraz A, Andó B, Rigó P, Harmatta J, Takách G, Zalka Z, et al. The two-faceted nature of impulsivity in
patients with borderline personality disorder and substance use disorder. Drug Alcohol Depend. 2016; 163:
-54. doi: 10.1016/j.drugalcdep.2016.03.015. PMID: 27107850.
Alemikhah M, Faridhosseini F, Kordi H, Rasouli-Azad M, Shahini N. Comparative Study of the Activity of
Brain Behavioral Systems in Methamphetamine and Opiate Dependents. Int J High Risk Behav Addict.
; 5(1). doi: 10.5812/ijhrba.25075. PMID: 27218066, PMCID: PMC4870470.
Paris J. The nature of borderline personality disorder: multiple dimensions, multiple symptoms, but one
category. J Pers Disord. 2007; 21(5): 457. doi: 10.1521/pedi.2007.21.5.457. PMID: 17953501.
Barker V, Romaniuk L, Cardinal R, Pope M, Nicol K, Hall J. Impulsivity in borderline personality
disorder. Psychol Med. 2015; 45(09): 1955-64. doi: 10.1017/S0033291714003079. PMID: 25600066.
Bornovalova MA, Lejuez C, Daughters SB, Rosenthal MZ, Lynch TR. Impulsivity as a common process
across borderline personality and substance use disorders. Clin Psychol Rev. 2005; 25(6): 790-812. doi:
1016/j.cpr.2005.05.005. PMID: 16005556.
Kruedelbach N, McCormick RA, Schulz SC, Grueneich R. Impulsivity, coping styles, and triggers for
craving in substance abusers with borderline personality disorder. J Pers Disord. 1993; 7(3): 214-22. doi:
1521/pedi.1993.7.3.214.
Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use
disorders: A review and integration. Clin Psychol Rev. 2000; 20(2): 235-53. doi: 10.1016/S0272- 7358(99)00028-8. PMID: 10721499.
Derefinko KJ, Widiger TA. Antisocial personality disorder. The medical basis of psychiatry: Springer.
: 229-45. doi: 10.1007/978-1-4939-2528-5_13.
Li D, Zhao H, Kranzler HR, Oslin D, Anton RF, Farrer LA, et al. Association of COL25A1 with comorbid
antisocial personality disorder and substance dependence. Biol Psychiatry. 2012; 71(8): 733-40. doi:
1016/j.biopsych.2011.12.011. PMID: 22297151, PMCID: PMC3548659.
Farid Hoseini F, Kaviani H, Asadi SM, Ali Malayeri N, Moghaddas Bayat MR. Character and temperament
in patients with anti-social personality and its comparison with Iran society norm. Cognitive Sciences News
; 9: 54-60.
Moody L, Franck C, Bickel WK. Comorbid depression, antisocial personality, and substance dependence:
Relationship with delay discounting. Drug Alcohol Depend. 2016; 160: 190-6. doi:
1016/j.drugalcdep.2016.01.009. PMID: 26846198, PMCID: PMC4767536.
Repo-Tiihonen E, Hallikainen T. Antisocial personality disorder. Duodecim. 2015; 132(2): 130-6. PMID:
Alcorn JL 3rd, Gowin JL, Green CE, Swann AC, Moeller FG, Lane SD. Aggression, impulsivity, and
psychopathic traits in combined antisocial personality disorder and substance use disorder. J
Neuropsychiatry Clin Neurosci. 2013; 25(3): 229-32. doi: 10.1176/appi.neuropsych.12030060. PMID:
, PMCID: PMC4777890.
Farid Hosseini f. Evaluation of risky decision-making in patients with antisocial personality disorders and
its relationship with personality dimensions. 2007.
Bechara A, Damasio H. Decision-making and addiction (part I): impaired activation of somatic states in
substance dependent individuals when pondering decisions with negative future consequences.
Neuropsychologia. 2002; 40(10): 1675-89. PMID: 11992656.
Devens M. Personality disorders. Primary Care: Clinics in Office Practice. 2007; 34(3): 623-40. doi:
1016/j.pop.2007.05.008.
Kraus G, Reynolds DJ. The “AB-C's” of the Cluster B's: Identifying, understanding, and treating Cluster B
personality disorders. Clin Psychol Rev. 2001; 21(3): 345-73. doi: 10.1016/S0272-7358(99)00052-5.
PMID: 11288605.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 knowledge kingdom publishing
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
